Arjuna Capital

Position in GSK — GSK plc

CIK 1703208 MANCHESTER, MA

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,103,486

+$303,968 QoQ

Shares Held

135,511

+10.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

1.85%

of 13F equity value

Holder Rank

#131

of 1,033 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arjuna Capital holds $20,631,399 across 5 Drug Manufacturers - General names. GSK ranks #1 (34.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc This page	135,511	$7,103,486
2	LLY	ELI LILLY & Co	4,447	$5,333,865
3	NVS	Novartis AG	28,989	$4,543,156
4	AMGN	Amgen Inc	6,166	$2,232,831
5	SNY	Sanofi	33,241	$1,418,061

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,103,486	135,511	+10.0%	Shares	Sole	2026-08-14
2026-03-31	$6,799,518	123,202	+3.8%	Shares	Sole	2026-05-06
2025-12-31	$5,821,342	118,706	-0.0%	Shares	Sole	2026-02-05
2025-09-30	$5,124,947	118,743	+1.4%	Shares	Sole	2025-11-04
2025-06-30	$4,498,982	117,161	-5.0%	Shares	Sole	2025-08-13
2025-03-31	$4,777,804	123,330	-25.3%	Shares	Sole	2025-05-09
2024-12-31	$5,582,532	165,066	+109.1%	Shares	Sole	2025-02-07
2024-09-30	$3,226,821	78,934	+144.3%	Shares	Sole	2024-11-05
2024-06-30	$1,244,050	32,313	+0.7%	Shares	Sole	2024-07-29
2024-03-31	$1,375,183	32,078	+2.6%	Shares	Sole	2024-05-13
2023-12-31	$1,158,236	31,253	-4.1%	Shares	Sole	2024-02-08
2022-06-30	$1,391,233	32,586	+2.8%	Shares	Sole	2022-07-22
2022-03-31	$1,354,809	31,711	+28.1%	Shares	Sole	2022-05-12
2021-12-31	$1,071,080	24,763	+34.8%	Shares	Sole	2022-02-11
2020-06-30	$734,885	18,369	+1.3%	Shares	Sole	2020-08-13
2020-03-31	$674,053	18,138	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.